Based on the SMILES representation CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1, the molecule has a half life in humans after IV administration of 4.400 hours.
Based on the {SMILES__description} {#representation |!}{SMILES#}, the molecule has a {half_life_duration__names__noun} of {half_life_duration#} {half_life_duration__units}.
2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide